Several reports have suggested that TGF-β1 can induce EMT in prostate epithelial cells and also in mouse tumor model by targeting deletion of SMAD3, and hence indicating toward potential of TGF-β signaling in prostatic cancer metastasis. Here, TGFB1 is linked to prostate cancer.